DOCG.L vs. BIGT.L

Last updated Jun 5, 2026

DOCG.L (L&G Healthcare Breakthrough UCITS ETF) and BIGT.L (L&G Pharma Breakthrough UCITS ETF) are both Health & Biotech Equities funds from Legal & General - DOCG.L tracks the MSCI World/Health Care NR USD while BIGT.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, DOCG.L returned -2.78%/yr vs 2.49%/yr for BIGT.L. A 0.65 correlation means they provide meaningful diversification when combined. Both charge a 0.49% expense ratio.

Performance

DOCG.L vs. BIGT.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in L&G Healthcare Breakthrough UCITS ETF (DOCG.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DOCG.L achieves a 0.55% return, which is significantly higher than BIGT.L's -0.70% return.

DOCG.L

• 1D: 5.29%
• 1M: 7.84%
• YTD: 0.55%
• 6M: -0.55%
• 1Y: 32.51%
• 3Y*: 4.33%
• 5Y*: -2.78%
• 10Y*: —

BIGT.L

• 1D: 2.65%
• 1M: -3.25%
• YTD: -0.70%
• 6M: -3.88%
• 1Y: 25.65%
• 3Y*: 2.96%
• 5Y*: 2.49%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DOCG.L vs. BIGT.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
DOCG.L L&G Healthcare Breakthrough UCITS ETF	0.55%	16.50%	3.57%	-6.64%	-25.94%	1.46%	63.33%	0.69%
BIGT.L L&G Pharma Breakthrough UCITS ETF	-0.70%	27.03%	-3.16%	-14.88%	2.68%	-2.30%	23.89%	1.46%

Correlation

The correlation between DOCG.L and BIGT.L is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.63
Correlation (3Y) Calculated over the trailing 3-year period	0.61
Correlation (5Y) Calculated over the trailing 5-year period	0.66
Correlation (All Time) Calculated using the full available price history since Jul 15, 2019	0.65

The correlation between DOCG.L and BIGT.L has been stable across timeframes, ranging from 0.61 to 0.66 - a consistent structural relationship.

DOCG.L vs. BIGT.L - Sectors Allocation Comparison

Sectors	DOCG.L	BIGT.L
Healthcare	98.0%	97.3%
Technology	2.0%	-
Basic Materials	-	2.7%
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

DOCG.L vs. BIGT.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCG.L

DOCG.L Risk / Return Rank: 43
DOCG.L Sharpe Ratio Rank: 47
DOCG.L Sortino Ratio Rank: 49
DOCG.L Omega Ratio Rank: 44
DOCG.L Calmar Ratio Rank: 42
DOCG.L Martin Ratio Rank: 32

BIGT.L

BIGT.L Risk / Return Rank: 43
BIGT.L Sharpe Ratio Rank: 40
BIGT.L Sortino Ratio Rank: 41
BIGT.L Omega Ratio Rank: 37
BIGT.L Calmar Ratio Rank: 53
BIGT.L Martin Ratio Rank: 45

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DOCG.L vs. BIGT.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF (DOCG.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DOCG.L	BIGT.L	Difference
Sharpe ratio: Return per unit of total volatility	1.62	1.39	+0.23
Sortino ratio: Return per unit of downside risk	2.38	2.04	+0.34
Omega ratio: Gain probability vs. loss probability	1.28	1.24	+0.04
Calmar ratio: Return relative to maximum drawdown	2.04	2.57	-0.53
Martin ratio: Return relative to average drawdown	4.71	7.42	-2.71
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DOCG.L vs. BIGT.L - Sharpe Ratio Comparison

The current DOCG.L Sharpe Ratio is 1.62, which is comparable to the BIGT.L Sharpe Ratio of 1.39. The chart below compares the historical Sharpe Ratios of DOCG.L and BIGT.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DOCG.L	BIGT.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.62	1.39	+0.23
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.13	0.15	-0.27
Sharpe Ratio (All Time) Calculated using the full available price history	0.23	0.22	+0.01

Drawdowns

DOCG.L vs. BIGT.L - Drawdown Comparison

The maximum DOCG.L drawdown since its inception was -51.45%, which is greater than BIGT.L's maximum drawdown of -30.23%. Use the drawdown chart below to compare losses from any high point for DOCG.L and BIGT.L.

Drawdown Indicators

	DOCG.L	BIGT.L	Difference
Max Drawdown Largest peak-to-trough decline	-51.45%	-30.23%	-21.22%
Max Drawdown (1Y) Largest decline over 1 year	-15.84%	-9.93%	-5.91%
Max Drawdown (3Y) Largest decline over 3 years	-25.52%	-23.74%	-1.78%
Max Drawdown (5Y) Largest decline over 5 years	-49.65%	-30.23%	-19.42%
Current Drawdown Current decline from peak	-27.42%	-5.41%	-22.01%
Average Drawdown Average peak-to-trough decline	-27.11%	-10.57%	-16.54%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.89%	3.45%	+3.44%

Volatility

DOCG.L vs. BIGT.L - Volatility Comparison

L&G Healthcare Breakthrough UCITS ETF (DOCG.L) has a higher volatility of 6.96% compared to L&G Pharma Breakthrough UCITS ETF (BIGT.L) at 6.35%. This indicates that DOCG.L's price experiences larger fluctuations and is considered to be riskier than BIGT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DOCG.L	BIGT.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.96%	6.35%	+0.61%
Volatility (6M) Calculated over the trailing 6-month period	15.16%	14.10%	+1.06%
Volatility (1Y) Calculated over the trailing 1-year period	19.93%	18.38%	+1.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.99%	16.86%	+5.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.45%	18.38%	+5.07%

DOCG.L vs. BIGT.L - Expense Ratio Comparison

Both DOCG.L and BIGT.L have an expense ratio of 0.49%.

Dividends

DOCG.L vs. BIGT.L - Dividend Comparison

Neither DOCG.L nor BIGT.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both DOCG.L and BIGT.L in my portfolio?

DOCG.L and BIGT.L have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, DOCG.L or BIGT.L?

Both ETFs have the same 0.49% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, DOCG.L or BIGT.L?

DOCG.L and BIGT.L have the same expense ratio: 0.49% per year.

What is the main difference between DOCG.L and BIGT.L?

DOCG.L tracks MSCI World/Health Care NR USD, while BIGT.L tracks NASDAQ Biotechnology TR USD.